Literature DB >> 12617151

Pathogen inactivation in cellular blood components: clinical trials and implications of introduction to transfusion medicine.

James P AuBuchon1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12617151     DOI： 10.1111/j.1423-0410.2002.tb05316.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  2 in total

Review 1.  Infectious risks associated with the transfusion of blood components and pathogen inactivation in Japan.

Authors:  Masahiro Satake
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

Review 2.  Emerging infections in transfusion medicine.

Authors:  Eberhard W Fiebig; Michael P Busch
Journal:  Clin Lab Med       Date:  2004-09       Impact factor: 1.935
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.